Content about Decongestants

November 15, 2010

The Food and Drug Administration has approved a generic treatment made by Impax for seasonal...

HAYWARD, Calif. — The Food and Drug Administration has approved a generic treatment made by Impax for seasonal allergies, Impax said Tuesday.

 

The drug maker announced the approval of its generic version of Sanofi-Aventis’ Allegra-D (fexofenadine hydrochloride and pseudoephedrine hydrochloride) tablets in the 60-mg/120-mg strength.

 

 

September 7, 2010

The Consumer Healthcare Products Association is slated to testify Wednesday before an Indiana legislative committee...

August 22, 2010

The industry-supported Combat Meth-amphetamine Enhancement Act, H.R. 2923, passed muster at the House Committee on...

July 18, 2010

The Consumer Healthcare Products Association in June commended the California Senate Public Safety Committee for...

June 24, 2010

Procter & Gamble voluntarily recalled its 4-hour decongestant nasal spray, a product distributed nationwide in...

CINCINNATI Procter & Gamble voluntarily recalled its 4-hour decongestant nasal spray, a product distributed nationwide in the United States.

P&G said it is taking this voluntary precautionary step after finding that the product formulation for VapoSpray 4-hour nasal spray by Sinex may not meet the expiration dates on the package. This recall is not a result of consumer complaints, the company noted.

 

June 23, 2010

The Consumer Healthcare Products Association on Tuesday commended the California Senate Public Safety Committee for...

June 6, 2010

Did the Combat Meth Act of 2005 not go far enough? Should the common and...

May 31, 2010

Former White House drug policy spokesman Robert Weiner and Jonathan Battaglia, a policy analyst at...

May 16, 2010

Electronic tracking or prescription-only? That’s the question that vexed Congressional leaders last month as they...

May 16, 2010

Target started an ad campaign last year called “Ask Us,” and here the retailer is...

Target started an ad campaign last year called “Ask Us,” and here the retailer is taking a bull's-eye approach against allergies by not only promoting their knowledgeable pharmacists as the friendly neighborhood allergy experts, but also directing consumers as to where they can find the popular decongestant pseudoephedrine.

March 22, 2010

Kansas announced last week that it will be the fifth state to implement the National...

March 8, 2010

Missouri has selected the National Precursor Log Exchange to serve as its statewide, real-time electronic...

February 17, 2010

The Oklahoma House Public Safety Committee voted on Wednesday to create a state registry of...

January 21, 2010

Four Mississippi legislators earlier this month added the Magnolia State as one of those states...

November 19, 2009

In a nutshell, this program gives any legislative body — state or local — debating...

NEW YORK In a nutshell, this program gives any legislative body — state or local — debating around whether a prescription ought to be required in the purchase of a pseudoephedrine product one less reason to pull the trigger on that decision. And it’s a pretty big reason. Before, the argument could be made that implementing a program like NPLEx was prohibitive because of the associated cost.

October 18, 2009

There is a big danger here, and it’s a danger that has less to do...

NEW YORK There is a big danger here, and it’s a danger that has less to do with the neighborhood meth addict in search of pseudoephedrine, and more to do with appropriate access to medicines and who gets to be the gatekeeper to that access. Because not only will a prescription-only PSE restrict consumer access to a legitimate nonprescription cough-cold ingredient, but if successfully mandated by the local government, it also has the potential to limit legitimate access to just about any cost-saving OTC medicine and for just about any reason.

 

August 6, 2009

The objective here is closing down clandestine methamphetamine labs. The question is: Who is going...

NEW YORK The objective here is closing down clandestine methamphetamine labs. The question is: Who is going to bear the cost? And the answer, ultimately, is the consumer.

It seems that one of the primary reasons behind legislation like this, which is also under consideration by the California state legislature as well as several local municipalities throughout Missouri, is cost shifting.

July 19, 2009

In the short term, it means pharmacists operating out of one of the 12 or...

NEW YORK In the short term, it means pharmacists operating out of one of the 12 or so pharmacies in Washington, Mo., will need to see a doctor’s prescription before filling any pseudoephedrine requests.

June 4, 2009

Attempting to curtail methamphetamine production by more or less eliminating the precursor ingredient pseudoephedrine from...

NEW YORK Attempting to curtail methamphetamine production by more or less eliminating the precursor ingredient pseudoephedrine from the market is kind of like throwing out the baby with the bathwater. PSE is a legitimate self-care option that is, according to general consensus, more effective than the other cough-cold decongestant on the market — phenylephrine. And restricting access to that self-care option hurts legitimate consumers more than it does meth cooks. But more on that in a second.

 

February 28, 2007

The most significant event that occurred during a soft 2006-2007 cough-and-cold season was the shift of the decongestant pseudoephedrine behind the counter in all 50 states. To be sure, some states still require more strict regulations on the sale of PSE, but at least now PSE is behind the counter in a legislative effort to thwart homegrown methamphetamine makers.

The most significant event that occurred during a soft 2006-2007 cough-and-cold season was the shift of the decongestant pseudoephedrine behind the counter in all 50 states. To be sure, some states still require more strict regulations on the sale of PSE, but at least now PSE is behind the counter in a legislative effort to thwart homegrown methamphetamine makers. Click below to download the PDF of ECRM Cough/Cold 2007.